It can also target XBP1 to protect the function of dopaminergic neurons, inhibit the expression of iNOS by inhibiting JNK signals, promote the autophagy ability of PD mouse neuronal cells, and reduce damage to dopaminergic neurons [153, 154]. This evidence concerns the gene MAPK8 and Parkinson disease.